FDA NDC Directory · JSON-LD · Markdown

BASAGLAR Tempo Pen

NDC 0002-8214 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameInsulin glargine
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA205692
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (100 [iU]/mL)
Marketing started20151216
Marketing ended20260727
Package count1

External sources

Source: openFDA. Public-domain (CC0).